EMOGLOBIN released from hemolysed erythrocytes has been postulated to underlie delayed cerebral vasospasm after subarachnoid hemorrhage (SAH). 29 However, the evidence is indirect 27 because it is based on the measurement of hemoglobin, or its products, in cerebrospinal fluid (CSF) that was collected at a distance from the artery in spasm. 5, 7 In addition, because of its impurity, 25 the use of bovine hemoglobin in some in vivo experiments 29-31 makes the results inconclusive.
catheter made from a semipermeable membrane with a 100-kD molecular weight cut-off was placed above the right MCA. The artery and catheter were then covered with 5 ml of saline (control group, three monkeys) or preclotted arterial blood (SAH group, six monkeys). 8, 29, 43 One end of the catheter was connected to a microosmotic pump and the other end was connected to an Ommaya reservoir (volume 0.54 ml) buried under the skin on the animal's back. The total volume of fluid inside the catheter and the microdialysis fiber was 0.03 to 0.04 ml. The pump delivered 0.28 ml of distilled water per day for 7 days. It was changed on Day 7 when the animal was anesthetized for the postoperative arteriography. A preliminary in vitro study revealed that measured concentrations of hemoglobin were 70 Ϯ 8% of the available hemoglobin (10 Ϫ5 M; measured three times) using this microdialysis system. The animals were killed on Day 13 postsurgery, and the position of the catheter was confirmed at autopsy.
Arteriographic Studies
To assess vasospasm, cerebral arteriography was performed 4 days before surgery and on Day 7 postoperatively, using methods described elsewhere. 43 Briefly, the monkeys were anesthetized with intramuscular injections of ketamine (10 mg/kg) and xylazine (Rompun, 1 mg/kg) and intubated and ventilated (PCO 2 = 40 mm Hg). A femoral artery cutdown was performed under aseptic conditions, and a No. 3 (animals weighing Ͻ 5 kg) or No. 4 (animals weighing Ͼ 5 kg) French polyethylene catheter was advanced with the aid of fluoroscopic guidance to the right internal carotid artery. Contrast medium (0.5-0.75 ml Conray 60%) was injected by hand. The filming sequence was conducted at two films per second for 3 seconds, and then one film per second for 6 seconds. All filming was performed at a magnification factor of 2. Subtraction films of the anteroposterior (AP) projections were made. The presence of vasospasm was detected by comparing the results of cerebral arteriographic studies of the right MCA obtained before surgery with the results of studies obtained on Day 7 postsurgery. A computerized image analysis system for the Macintosh computer was used to measure the area of the proximal 14 mm of the right MCA using the AP projection. Vasospasm was recognized if the pre-and postoperative arteriographic measurements of the right MCA indicated narrowing of the vessel lumen (11-25% reduction in AP area, mild vasospasm; 26-50%, moderate vasospasm; and Ͼ 50%, severe vasospasm).
Sample Collection
Microdialysate samples, approximately 0.28 ml each day, were collected by direct puncture of the Ommaya reservoir daily for 12 days and were stored at Ϫ70˚C. Because the pump was primed before placement under the skin and there was a "dead space" in the catheters (0.03-0.04 ml), samples obtained on the 1st day postsurgery were not used for analysis.
Measurements of Hemoglobin
The concentrations of oxyhemoglobin, deoxyhemoglobin, and methemoglobin were measured by means of spectrophotometry. The absorbance of the samples was measured three times at each wavelength (A560, A576, A578, and A630) and the mean value of the measurements was used for calculation of the hemoglobin concentrations as follows: for oxyhemoglobin: 21 {Oxy Hb} = (1.55 A578 Ϫ 0.861 A562 Ϫ 0.689 A598) / 6.45; for deoxyhemoglobin: 
Statistical Analysis
The data were analyzed by analysis of variance, with data from postoperative Days 2 through 12 used for the calculations. The values for Day 1 were excluded from the analysis because the oxyhemoglobin concentrations were exceptionally high, probably because of extracorporeal preparation of the clot. This theory was confirmed by an in vitro study that showed an increase of oxyhemoglobin in mock CSF immediately after exposure to the extracorporeally clotted arterial blood. Statistical significance was defined as a probability value of less than 0.05.
Sources of Supplies and Equipment
The microdialysis catheters were obtained from CMA/Microdialysis, Dalvagen, Sweden, and the microosmotic pump (Alzet 2ML1) was purchased from Alza, Inc., Palo Alto, CA. The contrast medium was acquired from Mallinckrodt Medical, Inc., St. Louis, MO. The image analysis system software (Image 1.54) was developed by Wayne Rasband, National Institutes of Mental Health, Bethesda, MD. The Macintosh computer was purchased from Apple Computer Corp., Cupertino, CA, and the Statview+Graphics software was supplied by Abacus Concepts, Inc., Berkeley, CA.
Results
Arteriographic vasospasm of the right MCA developed in all monkeys with subarachnoid clots (11-50% decrease of the projected AP area of the right MCA; 32 Ϯ 13%; mean Ϯ standard deviation) but in none of the control monkeys (Ϫ9 to 9% decrease; Ϫ2 Ϯ 1%). In the control monkeys the hemoglobin levels peaked on Day 2 (oxyhemoglobin, 8 Ϯ 6 ϫ 10 Ϫ7 M; deoxyhemoglobin 3 Ϯ 5 ϫ 10 Ϫ7 M; methemoglobin 2 Ϯ 3 ϫ 10 Ϫ6 M; p Ͻ 0.05 compared with Days 5-12) and then disappeared from the microdialysate samples on Day 5. In the monkeys with SAH the concentration of hemoglobins was much higher than in the control animals. The oxyhemoglobin levels ( 
Discussion

Microdialysis System
Ever since delayed cerebral vasospasm after SAH was related to posthemorrhagic changes in CSF, 5 research on the etiology of vasospasm has focused on blood, erythrocytes, and hemoglobin 6, 29, 30 and its metabolites. 6, 7, 10, 25, 29, 30, 32, 49 Oxyhemoglobin, a product of erythrocyte lysis, seems to be the molecule that is most likely to be responsible for the occurrence of delayed vasospasm after SAH, 29 although methemoglobin, 6, 30 bilirubin, 7, 32, 49 hemin, 25 and iron ions 10, 17 have also been implicated. The major difficulty with these various studies is that the concentrations of the different substances in the CSF samples collected from the ventricles, lumbar space, or subarachnoid cisterns are extrapolated to be the concentrations in the perivascular space immediately contiguous to spastic vessels. It is known, however, that the concentrations of CSF constituents differ depending on the region from which they were collected. 44 Moreover, the concentrations of CSF constituents are different in the perivascular space and the subarachnoid space. 52 Another pitfall in previous experiments is directly related to the measurement of oxyhemoglobin in the CSF, because deoxyhemoglobin in the CSF is converted to oxyhemoglobin 14 by exposure to the oxygen in the fluid, 44 as well as by exposure of the CSF samples to air. The oxyhemoglobin levels in the CSF samples could, therefore, be artificially inflated. These problems may un-derlie the wide variation in the correlation between the CSF oxyhemoglobin concentrations and cerebral vasospasm. 37, 54 In an attempt to overcome these problems, we developed an in vivo closed microdialysis system for continuous monitoring of hemoglobin in the perivascular space. Because the molecular weight of hemoglobin is 64,500, we used a semipermeable membrane with a very high molecular weight cut-off (100 kD). This system allowed us to collect fluid samples from the space directly surrounding the vessel. We monitored changes in the concentrations of the hemoglobins in the direct vicinity of a vessel during the development of posthemorrhagic cerebral spasm. This method, however, does not measure the exact levels of hemoglobin in the perivascular space; the levels of hemoglobin measured in in vitro testing were 70 Ϯ 8% of the known hemoglobin concentration in the solution. Furthermore, the partial removal of hemoglobin from the perivascular space by sample collection did not affect the incidence or degree of vasospasm characteristic of this model.
8,29,43
Levels of Hemoglobins
Oxyhemoglobin. Although oxyhemoglobin has long been considered responsible for evoking vasospasm, 6, 27 the experimental and clinical evidence supporting this hypothesis is indirect. The reported levels of hemoglobin range from 5 ϫ 10 Ϫ4 M in a subarachnoid hematoma 37 to 3 ϫ 10 Ϫ5 M in the CSF. 37, 54 In the current study microdialysis detected corresponding levels of oxyhemoglobin (0.5 ϫ 10 Ϫ4 M). However, the true level of hemoglobin could be approximately 30% higher than the values measured here, for the reason mentioned previously. Nevertheless, the results demonstrate the usefulness of our method for assessing the perivascular concentration of hemoglobins and support a role for oxyhemoglobin in the development of delayed cerebral vasospasm after SAH. The results also indicate that deoxyhemoglobin may contribute to the development of vasospasm.
Deoxyhemoglobin. This hemoglobin has received scant attention in delayed cerebral vasospasm, 54 perhaps because investigational samples are usually collected from the CSF, in which oxygen tension is high (31-47 mm Hg) 12, 44 and in which at least 75% of deoxyhemoglobin is converted to oxyhemoglobin. 12 Exposure of test samples to oxygen levels that are higher than those within the clot could falsely produce the impression that oxyhemoglobin, and not deoxyhemoglobin, is present in the CSF samples. Because our method of measuring hemoglobin levels (spectrophotometry) did not allow us to continue anaerobic conditions, we also could not completely avoid errors of oxygen exposure. Nevertheless, despite the conversion of deoxyhemoglobin to oxyhemoglobin during measurement, a significant increase in deoxyhemoglobin occurred in the perivascular samples at the time of vasospasm, and the level of deoxyhemoglobin was significantly higher
J. Neurosurg. / Volume 88 / March, 1998
Perivascular microdialysis after subarachnoid hemorrhage than earlier values reported in the CSF (0.003-5 ϫ 10 Ϫ5 M compared with 0.2 Ϯ 0.2 ϫ 10 Ϫ4 M). 54 Potential involvement of deoxyhemoglobin in the production of vasospasm after SAH is further supported by a recent magnetic resonance imaging study in which oxyhemoglobin is rapidly (within hours) and completely converted into deoxyhemoglobin after hemorrhage, 2, 13, 23 especially in the thick layer of subarachnoid blood 2 that is known to be responsible for delayed vasospasm. 9 Methemoglobin. Levels of this hemoglobin did not change significantly during the time of vasospasm but significantly increased on Day 12, when vasospasm in this model usually resolves. 42 Thus, these results confirm that methemoglobin is not directly involved in vasospasm, 29 as suggested earlier.
6,30
Pathophysiological Mechanisms of Vasospasm
Although oxyhemoglobin has been widely accepted as a direct cause of vasospasm, it is still unclear which of its diverse mechanisms of action, 27 if any, is responsible for evoking vasospasm. Recent studies have excluded or supported the following mechanisms: formation of oxygen radicals, 24, 28 release of free radicals and initiation of lipid peroxidation, 3, 47 release of eicosanoids, 33 development of proliferative arteriopathy, 43 and release of endothelin-1.
40,45
Other mechanisms, such as scavenging of endotheliumderived relaxing factor (EDRF)-nitric oxide (NO) 11, 50 or damage to adventitial nerves, 16, 20, 42 remain under investigation.
Our results confirm a role for oxyhemoglobin and/or deoxyhemoglobin as the cause of vasospasm after SAH by the correlation of peak levels of perivascular oxyhemoglobin and deoxyhemoglobin during the interval of delayed cerebral vasospasm. Recognition of NO as an EDRF 38 and the description of a "sink effect" in which hemoglobin binds NO 19,22 explain a potential mechanism by which oxyhemoglobin decreases EDRF. This mechanism is further supported by the reversal 1 and prevention of vasospasm 41 by a direct intracarotid infusion of an NO donor. However, deoxyhemoglobin, as oxyhemoglobin, also scavenges NO 19, 22 in a reaction that produces a stable nitrosylhemoglobin. 19, 53 Thus, both hemoglobins eliminate the action of this vasodilatory agent, 11, 19, 22, 50 and vasospasm could be produced by the unopposed action of constricting agents 39, 51 like endothelin-1. 40, 45 The existence of such a mechanism is further supported by the loss of vasodilatory properties of the vessel wall 15, 35 with preservation of its vasoconstrictive abilities. 15 Although the limited penetration of oxyhemoglobin in the vessel wall may preclude a dramatic decrease in the availability of the NO that is produced by endothelial cells, 34 it has been shown that NOsynthase (NOS) activity is present in the nerve endings in the adventitia of conductive cerebral vessels as another source of NO for the vessel wall. 18, 36, 48 An arterial nerve plexus is formed by the nerves from the sphenopalatine ganglion, 36 stimulation of which increases CBF 46 by vasodilation of the cerebral vessels. 18, 48 Earlier reports have shown the disappearance of the nerve endings from the adventitia of vessels exposed to blood 16, 20 or oxyhemoglobin. 26 The presence of NOS-containing nerves in the adventitia opens a new mechanism of NO depletion by oxy(deoxy)hemoglobin-induced damage to the NOS-containing vasodilatory nerves. This hypothesis of the involvement of adventitial NOS-positive neurons in the production of vasospasm has been recently confirmed by our laboratory, 42 demonstrating the disappearance of NOS activity from the adventitial nerve endings in the cerebral vessels in spasm, while at the same time immunoreactivity of endothelial NOS was preserved in these vessels, which suggests a loss of vasodilatory input from the adventitia in response to the presence of blood in the subarachnoid space, and not a loss of NO produced by endothelial cells, as the cause of vasospasm. 42 The current experiment provides further evidence for direct involvement of oxyhemoglobin and deoxyhemoglobin, but not methemoglobin, in the development of delayed cerebral vasospasm. Deoxyhemoglobin involvement in vasospasm is further supported by our recent observation that treatment with a ferrous but not a ferric iron chelator prevents development of vasospasm in the primate model of SAH. 17 The influence of deoxyhemoglobin on NOS activity in the adventitia and scavenging of NO needs further elucidation.
